Actinogen Medical Limited's market cap is currently ―. The company's EPS TTM is $-0.004; its P/E ratio is -11.36; Actinogen Medical Limited is scheduled to report earnings on August 28, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 16.37M	AU$ 13.42M	AU$ 5.04M	AU$ 7.64M	AU$ 10.00M
Total Assets	AU$ 23.31M	AU$ 18.38M	AU$ 11.94M	AU$ 16.22M	AU$ 18.03M
Total Debt	AU$ 165.27K	AU$ 236.44K	AU$ 389.87K	AU$ 0.00	AU$ 0.00
Net Debt	AU$ -16.21M	AU$ -13.19M	AU$ -4.65M	AU$ -7.64M	AU$ -10.00M
Total Liabilities	AU$ 1.57M	AU$ 920.32K	AU$ 1.05M	AU$ 557.39K	AU$ 768.25K
Stockholders Equity	AU$ 21.74M	AU$ 17.46M	AU$ 10.89M	AU$ 15.66M	AU$ 17.26M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

Actinogen Medical Limited Earnings and Revenue History

Income Statement >

Actinogen Medical Limited Debt to Assets

Balance Sheet >

Actinogen Medical Limited Cash Flow

Cash Flow >

Actinogen Medical Limited Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing